
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Sodium Hyaluronate,UC-MSC-Derived Secretome
Therapeutic Area : Musculoskeletal
Study Phase : Phase II/ Phase III
Recipient : Universitas Sriwijaya
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Hyalein (Sodium Hyaluronate) is a small molecule drug, which is currently being evaluated in Phase II/ Phase III clinical studies for the treatment of osteoarthritis, knee.
Product Name : Hyalein
Product Type : Miscellaneous
Upfront Cash : Inapplicable
January 13, 2026
Lead Product(s) : Sodium Hyaluronate,UC-MSC-Derived Secretome
Therapeutic Area : Musculoskeletal
Highest Development Status : Phase II/ Phase III
Recipient : Universitas Sriwijaya
Deal Size : Inapplicable
Deal Type : Inapplicable
